Mechanistic insights into PD-1 inhibitor-associated immune thrombocytopenia: a case report integrating longitudinal transcriptomic profiling
Huishan Li, Yan Wang, Jianfeng Zhu, Hehui Chen, Tianshu Liu, Luoyan Ai · 2025
Read Mechanistic insights into PD-1 inhibitor-associated immune thrombocytopenia: a case report integrating longitudinal transcriptomic profiling by Huishan Li, Yan Wang, Jianfeng Zhu, Hehui Chen, Tianshu Liu, Luoyan Ai (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12766837.txt.
Description
Huishan Li and co-authors trace the cause of a rare side effect of cancer immunotherapy in a 2025 case report. The patient was an older man with stage four stomach cancer. After treatment with a PD-1 inhibitor, a targeted antibody, and chemotherapy, he twice developed immune thrombocytopenia, a drop in platelets that raises bleeding risk. The team sampled his blood cells before and after each episode.
Gene activity profiling across those time points let them watch the illness unfold twice in one person, the second time after the drug was tried again. Their analysis points to a two-part cause. The immune system destroys platelets, and the marrow cells that make platelets are themselves impaired. The authors offer this paired mechanism as a frame for the complication. They note the case is the first tracked this way over time.
Catalog record
| CREATOR | Huishan Li, Yan Wang, Jianfeng Zhu, Hehui Chen, Tianshu Liu, Luoyan Ai |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |